Investments in Cancer Control Research

For more than 25 years, researchers funded by DCCPS have been advancing the science to improve public health. Major programmatic areas of research include epidemiology and genomics, behavioral health, healthcare delivery, surveillance, health equity, implementation science, and cancer survivorship.

In fiscal year 2023, DCCPS funded approximately 900 grants valued at nearly $580 million, supporting work in the United States and internationally aimed to reduce risk, incidence, and deaths from cancer, and to enhance the quality of life for cancer survivors. In addition, the division funded $95 million in contracts, which include the SEER Program. While the majority of DCCPS funding is for investigator-initiated research project grants, the division also uses other strategies to support and stimulate research, such as multicomponent specialized research centers, cancer epidemiology cohorts, and supplements to NCI-Designated Cancer Center support grants.

Learn more about the DCCPS grant portfolio and funding trends at maps.cancer.gov/overview.